Back to top

Silo Pharma engages Resyca to conduct a robustness study for SPC-15 delivery

Silo Pharma (SILO) announced that it has engaged its drug-device development partner Resyca to conduct a robustness study evaluating the microchip-...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: